{"abstract":"The Food and Drug Administration (FDA) is announcing the availability of a guidance document for the public, FDA advisory committee members, and FDA staff entitled \"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers.\" This guidance is intended to help the public, FDA advisory committee members, and FDA staff to understand and implement FDA procedures regarding public availability of information regarding certain financial interests and waivers granted by FDA to permit individuals to participate in an advisory committee meeting. The guidance announced in this notice finalizes the draft guidance of the same title dated October 2007 and FDA's \"Draft Guidance on Disclosure of Conflicts of Interest for Special Government Employees Participating in FDA Product Specific Advisory Committees\" dated January 2002. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of three additional guidances, and one draft guidance, intended to improve FDA's advisory committee procedures.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2008/08/05/E8-17999.html","cfr_references":[],"citation":"73 FR 45459","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The guidance is effective August 5, 2008. Submit written or electronic comments on agency guidances at any time.","disposition_notes":null,"docket_ids":["Docket No. FDA-2002-D-0094"],"dockets":[],"document_number":"E8-17999","effective_on":"2008-08-05","end_page":45460,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2008/08/05/E8-17999.xml","html_url":"https://www.federalregister.gov/documents/2008/08/05/E8-17999/guidance-for-the-public-fda-advisory-committee-members-and-fda-staff-public-availability-of-advisory","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/E8-17999?publication_date=2008-08-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2008-08-05/E8-17999/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":48,"last_updated":"2026-09-21 20:15:12 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2008-08-05/pdf/E8-17999.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2008-08-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2008/08/05/E8-17999.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Appendix C - \"FDAAC August 30, 2010\" - [R.J. Reynolds Tobacco Company - Comment] re FDA-2002-D-0094-0018","document_id":"FDA-2002-D-0094-0023"},{"title":"Appendix A - \" RJReynolds Letter to FDA, June 30, 2010\" - [R.J. Reynolds Tobacco Company - Comment] re FDA-2002-D-0094-0018 ","document_id":"FDA-2002-D-0094-0022"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2002-D-0094","supporting_documents_count":2,"docket_id":"FDA-2002-D-0094","regulation_id_number":null,"title":"Disclosure of Conflicts of Interest for Special Government Employees","checked_regulationsdotgov_at":"2011-11-14T14:47:30Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":45459,"subtype":null,"title":"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers; Availability","toc_doc":"Public Availability of Advisory Committee Members Financial Interest Information and Waivers","toc_subject":"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff","topics":[],"type":"Notice","volume":73}